🔗 Permalink

Inventor profile of:

Mark T. Bilodeau

City:

Concord, Massachusetts

Country:

United States

Published Applications:

Last publication date:

2018-07-05

Top Assignees for applications by Mark T. Bilodeau

The entities that hold a legal rights for patent applications filed by inventor Bilodeau Mark T.:

Placon Therapeutics, Inc. 4 Watertown, MA United States
Tarveda Therapeutics, Inc. 4 Watertown, MA United States
PLACON THERAPEUTICS, INC. 4 Cambridge, MA United States
Blend Therapeutics 2 Watertown, MA United States
Blend Therapeutics, Inc. 2 Watertown, MA United States
PLACON THERAPEUTICS 1 Watertown, MA United States
PLACON THERAPEUTICS, INC. 1 Camridge, MA United States

Recent patent applications by Bilodeau Mark T.

Mark T. Bilodeau from Concord, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2018-07-05

US20180186823A1

Chemistry; metallurgy

PLATINUM COMPOUNDS, COMPOSITIONS, AND USES THEREOF

#2 | 2018-01-25

US20180021454A1

Human necessities

TARGETED CONJUGATES ENCAPSULATED IN PARTICLES AND FORMULATIONS THEREOF

#3 | 2018-01-11

US20180008614A1

Human necessities

Platinum compounds, compositions, and uses thereof

#4 | 2018-01-04

US20180000959A1

Human necessities

Targeted conjugates and particles and formulations thereof

#5 | 2017-12-07

US20170349615A1

Chemistry; metallurgy

Platinum compounds having a heterocycle ligand, nanoparticles, and uses thereof

#6 | 2017-11-02

US20170313733A1

Chemistry; metallurgy

Compounds, compositions, and methods for the treatment of cancers

#7 | 2017-11-02

US20170312245A1

Human necessities

Targeted conjugates and particles and formulations thereof

#8 | 2017-06-01

US20170151339A1

Human necessities

TARGETED CONJUGATES AND PARTICLES AND FORMULATIONS THEREOF

#9 | 2017-04-06

US20170095569A1

Human necessities

Targeted conjugates and particles and formulations thereof

#10 | 2017-03-30

US20170087118A1

Human necessities

Compounds, compositions, and methods for the treatment of cancers

#11 | 2016-11-10

US20160326201A1

Chemistry; metallurgy

Compounds, compositions, and methods for the treatment of cancers

#12 | 2016-11-03

US20160318962A1

Chemistry; metallurgy

Compounds, compositions, and methods for the treatment of cancers

#13 | 2016-11-03

US20160317549A1

Human necessities

Platinum compounds, compositions, and uses thereof

#14 | 2016-06-16

US20160166715A1

Human necessities

Nanoparticle Diagnostic and Methods for Treating Disease

#15 | 2016-06-02

US20160152646A1

Chemistry; metallurgy

Platinum compounds having a heterocycle ligand, nanoparticles, and uses thereof

#16 | 2016-03-17

US20160074526A1

Human necessities

SSTR-TARGETED CONJUGATES ENCAPSULATED IN PARTICLES AND FORMULATIONS THEREOF

#17 | 2016-03-10

US20160068557A1

Chemistry; metallurgy

Platinum compounds, compositions, and uses thereof

#18 | 2015-12-03

US20150344511A1

Chemistry; metallurgy

Compounds, compositions, and methods for the treatment of cancers

#19 | 2014-12-25

US20140378427A1

Human necessities

Cabazitaxel-platinum nanoparticles and methods of using same

#20 | 2014-07-03

US20140187501A1

Human necessities

Targeted Conjugates Encapsulated in Particles and Formulations Thereof

#21 | 2014-03-27

US20140088066A1

Chemistry; metallurgy

PLATINUM COMPOUNDS, COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER

InventorID:

704901 ⎘